FPC Investment Advisory Inc. Takes $27,000 Position in Humana Inc. (NYSE:HUM)

FPC Investment Advisory Inc. bought a new stake in shares of Humana Inc. (NYSE:HUM) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 106 shares of the insurance provider’s stock, valued at approximately $27,000.

Several other hedge funds have also recently made changes to their positions in the business. Fisher Funds Management LTD purchased a new position in shares of Humana during the fourth quarter valued at approximately $16,952,000. First Horizon Advisors Inc. grew its stake in Humana by 11.5% in the fourth quarter. First Horizon Advisors Inc. now owns 581 shares of the insurance provider’s stock worth $148,000 after purchasing an additional 60 shares during the period. Sigma Planning Corp grew its stake in Humana by 122.0% in the fourth quarter. Sigma Planning Corp now owns 1,456 shares of the insurance provider’s stock worth $369,000 after purchasing an additional 800 shares during the period. Deseret Mutual Benefit Administrators grew its stake in Humana by 18.0% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 399 shares of the insurance provider’s stock worth $101,000 after purchasing an additional 61 shares during the period. Finally, Camelot Portfolios LLC purchased a new stake in Humana in the fourth quarter worth $574,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Down 5.7 %

HUM opened at $255.77 on Friday. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a 50 day moving average price of $269.41 and a 200-day moving average price of $290.00. The stock has a market capitalization of $30.80 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 2.05 and a beta of 0.56.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.38%. Humana’s payout ratio is 35.58%.

Analyst Upgrades and Downgrades

HUM has been the topic of several recent research reports. Wells Fargo & Company reduced their price target on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Piper Sandler upped their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. TD Cowen upped their price objective on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Barclays upped their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $285.68.

Insider Buying and Selling at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.32% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.